ELK GROVE VILLAGE, Ill., June 29 /PRNewswire/ -- Wake Pharm US announced today the appointment of Jeffrey A. Niezgoda, MD, FACHM, FACEP, FAPWCA as Director of the Company’s Medical Advisory Board.
Dr. Jeffrey Niezgoda is a leading wound management physician and the Medical Director of the Centers for Comprehensive Wound Care and Hyperbaric Oxygen Therapy in Milwaukee, Wisconsin. He also serves as the President and Chief Operating Officer of Hyperbaric & Wound Care Associates, a medical specialty group serving Southeastern Wisconsin and Northern Illinois, and as the President of the American College of Hyperbaric Medicine.
Dr. Niezgoda stated, “I am very pleased to accept the position of Director of the Advisory Board and to have the opportunity to contribute to the company’s clinical mission. My clinical experience with Wound Be Gone(R) has produced impressive results with improved wound healing trajectories. Wound Be Gone(R) is placing wound care into the hands of people who might otherwise suffer or whose wound problems might escalate to need for expensive invasive medical intervention.”
Ludek Lolek, President & CEO of Wake Pharm US commented, “Dr. Niezgoda has been an invaluable resource to the Wound Be Gone(R) brand. His clinical insight and experience has been a tremendous asset to our development team. As Director of our Medical Advisory Board, Dr. Niezgoda will help us to accelerate the growth of our product line.”
Wound-Be-Gone(R) is a novel hydrophilic gel that has been shown to demonstrate enhanced wound healing in varied clinical settings with both acute and chronic wounds. The mechanism of action appears to be related to a decrease in inflammatory mediators due to the active scavenging of oxygen free radicals. Visit www.woundbegone.com for more details.
About Wake Pharm US:
Wake Pharm US is an innovative and international company with its own manufacturing facility located in the Czech Republic (European Union). Wake Pharm US specializes in developing, marketing and distribution of revolutionary and unique products to the health marketplace. For further information about Wake Pharm US, please visit our website at www.wakepharmus.com.
CONTACT: Damian Styga of Wake Pharm US, +1-224-366-3900,
dstyga@wakepharmus.com
Web site: http://www.wakepharmus.com/
